Listed

Church & Dwight Co Inc: Form 10-Q for the period ended Mar 31, 2017

Filed with the SEC on May 4, 2017 and accepted by EDGAR at May 4, 2017, 15:13 ET.

Share

Management's discussion and analysis

As filed, 21,613 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

RESULTS OF OPERATIONS

Results of Operations

Consolidated results

Three Months Ended March 31, 2017 Change vs. Prior Year Three Months Ended March 31, 2016
Net Sales $877.2 3.3% $849.0
Gross Profit $399.3 5.4% $379.0
Gross Margin 45.5% +90 basis points 44.6%
Marketing Expenses $90.8 (1.8%) $92.5
Percent of Net Sales 10.3% -60 basis points 10.9%
Selling, General & Administrative Expenses $112.4 5.0% $107.0
Percent of Net Sales 12.8% +20 basis points 12.6%
Income from Operations $196.1 9.2% $179.5
Operating Margin 22.4% +130 basis points 21.1%
Net income per share - Diluted $0.51 18.6% $0.43

Diluted Net Income per share was $0.51 as compared to $0.43 in the first quarter of 2016. During the first quarter of 2017, the Company closed on the previously announced transaction to sell its chemical business in Brazil. As a result, a pre and post- tax charge of $3.5 was recorded ($1.3 in cost of goods sold and $2.2 in selling, general and administrative expenses). This equated to $0.01 per share. Also during the quarter, the Company adopted a new accounting standard related to certain aspects of share-based payment awards to employees. This standard requires that any excess tax benefits related to share-based payment awards to employees be recorded as a reduction to income tax expense. Previously, this benefit was recorded in the stockholders’ equity section of the Balance Sheet. The amount recorded in the first quarter of 2017 as a reduction to income tax expense was $8.7 or $0.03 per share.

On August 4, 2016, the Company announced a two-for-one stock split of the Company’s common stock (“Common Stock”). The stock split was structured in the form of a 100% stock dividend, payable on September 1, 2016 to stockholders of record as of August 15, 2016. All applicable amounts in the consolidated financial statements and related disclosures have been retroactively adjusted to reflect the stock split.

Net Sales

Net sales for the three months ended March 31, 2017 were $877.2, an increase of $28.2 or 3.3% as compared to the same period in 2016. The components of the net sales increase are as follows:

Net Sales - Consolidated Three Months Ended March 31, 2017
Product volumes sold 2.7%
Pricing/Product mix (0.4%)
Foreign exchange rate fluctuations (0.6%)
Volume from acquired product lines (1) 1.6%
Net Sales increase 3.3%

(1) On December 22, 2016, the Company acquired the ANUSOL and RECTINOL (the “Anusol Acquisition”) business from Johnson & Johnson, Inc. On January 17, 2017, the Company acquired the VIVISCAL business (the “Viviscal Acquisition”) from Lifes2Good Holdings Limited. Net sales of these acquisitions are included in the Company’s results since the date of acquisition.

For the three months ended March 31, 2017, the volume change primarily reflects increased product sales in both the Consumer Domestic and Consumer International segments, with volume declines in Specialty Products (“SPD”).

Gross Profit / Gross Margin

The Company’s gross profit was $399.3 for the three months ended March 31, 2017, a $20.3 increase as compared to the same period in 2016. Gross margin increased 90 basis points (“bps”) in the first quarter of 2017 compared to the same period in 2016, primarily associated with cost improvement projects representing 100 bps and the impact of higher margins on acquired products representing 50 bps, partially offset by a 20 bps charge associated with selling the Company’s SPD business in Brazil, higher commodity costs of 20 bps, the impact of unfavorable foreign exchange rates of 10 bps and unfavorable price/mix of 10 bps.

Operating Expenses

Marketing expenses for the three months ended March 31, 2017 were $90.8, a decrease of $1.7 or 1.8% as compared to the same period in 2016. Marketing expenses as a percentage of net sales in the first quarter of 2017 were 10.3% as compared to 10.9% in 2016. The impact of higher sales contributed to a 40 bps reduction and the impact of lower costs contributed an additional 20 bps reduction.

Selling, general and administrative (“SG&A”) expenses were $112.4 in the three months ended March 31, 2017, an increase of $5.4 or 5.0% as compared to the same period in 2016. The increase is due to one-time and ongoing costs associated with the Viviscal and Anusol acquisitions, higher information technology costs and costs associated with selling the Company’s SPD business in Brazil, partially offset by lower incentive compensation costs. SG&A as a percentage of net sales increased 20 bps to 12.8% in the first quarter of 2017 as compared to 12.6% in the same period in 2016. The increase is due to higher costs of 60 bps, partially offset by 40 bps of leverage associated with higher sales.

Other Income and Expenses

Equity in earnings of affiliates for the three months ended March 31, 2017 increased by $0.4 as compared to the same period in 2016, primarily due to profit improvement from Armand Products due to lower raw material costs.

Other expense, net for the three months ended March 31, 2017 decreased $1.5 as compared to the same period in 2016 primarily due to costs incurred in 2016 associated with the Natronx joint venture.

Interest expense for the three months ended March 31, 2017 increased $1.4 as compared to the same periods in 2016 due to a higher amount of average debt outstanding and increased borrowing costs due to an increase in short-term interest rates.

Income Taxes

The effective tax rate for the three months ended March 31, 2017 was 30.9% compared to 34.7% in the same period in 2016. The reduction in the tax rate is primarily due to the tax benefit related to the adoption of the new accounting standard which modifies how companies account for certain aspects of share-based payment awards to employees. Previously this tax benefit was accounted for in the Company’s Stockholders’ Equity section of the Balance Sheet. Starting in 2017, the tax benefit is accounted for as a reduction of income tax expense, which represented 450 bps.

Segment results

The Company operates three reportable segments: Consumer Domestic, Consumer International and SPD. These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

Segment Products
Consumer Domestic Household and personal care products
Consumer International Primarily personal care products
SPD Specialty chemical products

The Corporate segment income consists of equity in earnings of affiliates. As of March 31, 2017, the Company held 50% ownership interests in each of Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), respectively, and a one-third ownership interest in Natronx. The Company’s equity in earnings of Armand and ArmaKleen for the three month periods ended March 31, 2017 and 2016 are included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment net sales and income before income taxes for the three month period ended March 31, 2017 and March 31, 2016 are as follows:

Net Sales(1) Consumer Domestic Consumer International SPD Corporate Total
First Quarter 2017 $659.7 $143.1 $74.4 $0.0 $877.2
First Quarter 2016 647.8 127.4 73.8 0.0 849.0
Income before Income Taxes(2)
First Quarter 2017 $160.9 $19.4 $7.8 $2.1 $190.2
First Quarter 2016 139.9 18.1 13.3 1.7 173.0

(1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $1.4 and $1.0 for the three months ended March 31, 2017 and March 31, 2016, respectively.

(2) In determining Income before Income Taxes, interest expense and investment earnings were allocated among the segments based upon each segment’s relative Income from Operations.

Product line revenues from external customers are as follows:

Three Months Ended March 31, 2017 March 31, 2016
Household Products $394.5 $388.3
Personal Care Products 265.2 259.5
Total Consumer Domestic 659.7 647.8
Total Consumer International 143.1 127.4
Total SPD 74.4 73.8
Total Consolidated Net Sales $877.2 $849.0

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care and hair care products and gummy dietary supplements.

Consumer Domestic

Consumer Domestic net sales for the three months ended March 31, 2017 were $659.7, an increase of $11.9 or 1.8% as compared to the same period in 2016. The components of the net sales change are the following:

Net Sales - Consumer Domestic Three Months Ended March 31, 2017
Product volumes sold 1.1%
Pricing/Product mix (0.3%)
Volume from acquired product lines (1) 1.0%
Net Sales increase 1.8%

(1) Includes net sales of the brands acquired in the Viviscal Acquisition since the date of acquisition.

The increase in net sales for the three months ended March 31, 2017, reflects higher sales of ARM & HAMMER liquid and unit dose detergents, BATISTE dry shampoo, ARM & HAMMER Baking Soda and ARM & HAMMER cat litter, partially offset by lower sales of TROJAN condoms and XTRA laundry detergent.

There continues to be significant product and price competition in the laundry detergent category. For example, the Procter & Gamble Company markets a lower-priced line of laundry detergents that competes directly with the Company’s core value laundry detergents. Henkel AG & Co. KGaA (“Henkel”) entered the U.S. market with Persil, its leading worldwide premium laundry detergent, and recently acquired The Sun Products Corporation (“Sun Products”), the maker of ALL, WISK and SUN laundry detergents. These actions have increased price competition and distribution pressures in the premium and extreme value laundry categories and could adversely impact sales and market share of the OXICLEAN and XTRA laundry detergents. The Company continues to evaluate and vigorously combat these pressures through, among other things, new product introductions, increased marketing and trade spending.

Consumer Domestic income before income taxes for the three months ended March 31, 2017 was $160.9, a $21.0 increase as compared to the same period in 2016. The increase is due primarily to favorable commodity and manufacturing costs of $10.7, the impact of higher sales volumes of $9.9, lower marketing expenses of $3.5 and lower SG&A costs of $3.0, partially offset by unfavorable price/mix of $4.6.

Consumer International

Consumer International net sales were $143.1 for the three months ended March 31, 2017, an increase of $15.7 or 12.3% as compared to the same period in 2016. The components of the net sales change are the following:

Net Sales - Consumer International Three Months Ended March 31, 2017
Product volumes sold 13.2%
Pricing/Product mix (1.4%)
Foreign exchange rate fluctuations / Other (3.3%)
Volume from acquired product lines (1) 3.8%
Net Sales increase 12.3%

(1) Includes net sales of the brands acquired in the Anusol Acquisition and the Viviscal Acquisition since the date of acquisition.

Excluding the impact of unfavorable foreign exchange rates, higher sales in the first quarter ended March 31, 2017 occurred in exports, Canada, Europe and Mexico and were attributable to the ARM & HAMMER liquid detergent brands, BATISTE, OXICLEAN and FEMFRESH.

Consumer International income before income taxes was $19.4 for the three months ended March 31, 2017, an increase of $1.3 compared to the same period in 2016 due primarily to higher volume of $13.2, partially offset by higher SG&A of $5.4, higher marketing costs of $2.8, unfavorable price/mix of $2.8 and unfavorable foreign exchange rates of $1.0.

International Pension Plan Termination

In 2016 the Company authorized the termination of international defined benefit pension plans under which approximately 336 participants, including 53 active employees, have accrued benefits. The Company anticipates completing the termination of this plan by the end of the second quarter of 2017, once regulatory approvals are obtained. In addition to plan assets, the Company estimates it will need to make a one-time payment of $14.0 to $20.0 ($9.0 to $14.0 after tax) to purchase annuities for participants. The Company estimates that it will incur a one-time expense of $44.0 to $50.0 ($36.0 to $41.0 after tax) in 2017 when the plan settlement is completed. This expense primarily includes the effect of the additional cash payment required at settlement and pension settlement accounting rules which require accelerated recognition of actuarial losses that were to be amortized over the expected benefit lives of participants. The estimated expense is subject to change based on valuations at the actual date of settlement. Upon the termination of these plans in 2017, the Company will have no further obligations with respect to material defined benefit pension plans.

Specialty Products (“SPD”)

SPD net sales were $74.4 for the three months ended March 31, 2017, an increase of $0.6 or 0.8% as compared to the same period in 2016. The components of the net sales change are the following:

Net Sales - SPD Three Months Ended March 31, 2017
Product volumes sold (2.1%)
Pricing/Product mix 1.8%
Foreign exchange rate fluctuations / Other 1.1%
Net Sales increase 0.8%

21

The net sales increase in the first quarter of 2017 was driven primarily by improved price and volumes in the animal productivity business due to higher demand from the U.S. dairy industry as milk prices and dairy farm profitability have stabilized, partially offset by lower volumes in SPD.

SPD income before income taxes was $7.8 for the three months ended March 31, 2017, a decrease of $5.5 as compared to the same period in 2016 due primarily to higher manufacturing costs of $4.1, costs associated with the sale of the Brazilian chemical business of $3.5, and higher SG&A of $1.3, partially offset by favorable price/mix of $1.3, lower costs associated with the Natronx joint venture of $1.1, and favorable foreign exchange rates of $0.4. Future costs associated with the sale of the Brazilian chemical business are expected to be immaterial.

Corporate

The administrative costs of the Company’s production, planning and logistics functions are included in the SG&A expenses of each operating segment and as elements of cost of sales in the Company’s Consolidated Statements of Income. The Corporate segment includes equity in earnings of affiliates from Armand and ArmaKleen in the first quarter of 2017 and 2016. The Corporate segment income before income taxes was $2.1 in the first quarter of 2017, as compared to $1.7 in the same period in 2016.

Liquidity and Capital Resources

As of March 31, 2017, the Company had $139.5 in cash and cash equivalents, $200 available under an unsecured Term Loan Credit Facility which became effective March 27, 2017, approximately $414 available through the revolving facility under its principal credit agreement (the “Credit Agreement”) and its commercial paper program, and a commitment increase feature under the Credit Agreement that enables the Company to borrow up to an additional $600.0, subject to lending commitments of the participating lenders and certain conditions as described in the Credit Agreement. To preserve its liquidity, the Company invests its cash primarily in government money market funds and short term bank deposits.

The current economic environment presents risks that could have adverse consequences for the Company’s liquidity. (See “Unfavorable economic conditions could adversely affect demand for the Company’s products” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “Form 10-K”.) The Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenant in the Credit Agreement because the Company currently is, and anticipates that it will continue to be, in compliance with the maximum leverage ratio requirement under the Credit Agreement.

On February 7, 2017, the Board declared a 7% increase in the regular quarterly dividend from $0.1775 to $0.19 per share, equivalent to an annual dividend of $0.76 per share payable to stockholders of record as of February 21, 2017. The increase raises the annual dividend payout from $183 to approximately $195, and maintains the Company’s payout of dividends relative to net income at approximately 40%.

In connection with the Company’s share repurchase program authorized by the Board in November 2016 (the “2016 Share Repurchase Program”) and its evergreen repurchase program, the Company purchased approximately 3.1 million shares in the first quarter of 2017 at a cost of approximately $157.1, of which approximately $125.0 was purchased under the evergreen share repurchase program and $32.1 was purchased under the 2016 Share Repurchase Program. The Company will continue its evergreen share repurchase program.

The Company anticipates that its cash from operations, together with its current borrowing capacity, will be sufficient to meet its capital expenditure program costs, which are expected to be a total of approximately $50.0 in 2017, fund its share repurchase programs to the extent implemented by management and pay dividends at the latest approved rate. Cash, together with the Company’s current borrowing capacity, may be used for acquisitions that would complement the Company’s existing product lines or geographic markets. The Company does not have any mandatory fixed rate debt principal payments in 2017.

Cash Flow Analysis

Three Months Ended March 31, 2017 March 31, 2016
Net cash provided by operating activities $131.5 $177.8
Net cash used in investing activities $(159.3) $(184.1)
Net cash used in financing activities $(24.4) $(136.1)

22

Net Cash Provided by Operating Activities – The Company’s primary source of liquidity is the strong cash flow provided by operating activities, which is dependent on the level of net income and changes in working capital. The Company’s net cash provided by operating activities in the three months ended March 31, 2017 decreased by $46.3 to $131.5 as compared to $177.8 in the same period in 2016 due to an increase in working capital, partially offset by higher cash earnings (net income plus non-cash expenses such as depreciation, amortization, non-cash compensation and asset impairment charges). The change in working capital is primarily due to a larger decrease in accounts payable and accrued expenses due to higher deferred compensation, incentive compensation and profit sharing payments of approximately $25.0, and larger increases in inventory and accounts receivable. However, the Company measures working capital effectiveness based on its cash conversion cycle. The following table presents the Company’s cash conversion cycle information for the three months ended March 31, 2017 and 2016:

As of March 31, 2017 March 31, 2016 Change
Days of sales outstanding in accounts receivable ("DSO") 30 29 1
Days of inventory outstanding ("DIO") 51 54 (3)
Days of accounts payable outstanding ("DPO") 64 57 (7)
Cash conversion cycle 17 26 (9)

The Company's cash conversion cycle (defined as the sum of DSO and DIO less DPO) which is calculated using a 2 period average method, improved 9 days from the prior year amount of 26 days to 17 days at March 31, 2017 due primarily to improved DPO of 7 days as the Company continues to extend payment terms with its suppliers. DIO improved 3 days from 54 to 51 days, offset by DSO which increased 1 day from 29 to 30 days. The improvement in the Company's cash conversion cycle reflects the Company's continued focus on reducing its average working capital requirements.

Net Cash Used in Investing Activities – Net cash used in investing activities during the first three months of 2017 was $159.3, primarily reflecting $160.3 for the Viviscal Acquisition and $2.8 for property, plant and equipment expenditures, partially offset by $4.5 of cash proceeds from the sale of the Brazil chemical business.

Net Cash Used in Financing Activities – Net cash used in financing activities during the first three months of 2017 was $24.4, primarily reflecting $157.1 of repurchases of the Company’s Common Stock, $48.4 of cash dividend payments, and $3.4 of short term debt repayments at an international subsidiary, partially offset by of $162.2 of commercial paper borrowings, and $22.7 of proceeds from stock option exercises.

Market risk

As filed, 346 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Market risk

For quantitative and qualitative disclosures about market risk affecting the Company, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. Our exposure to market risk has not changed materially since December 31, 2016.

Controls and procedures

As filed, 5,009 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (the “Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to net sales and earnings growth; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; sufficiency of cash flows from operations; earnings per share; the impact of new accounting pronouncements; cost savings programs; consumer demand and spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of competitive laundry detergent products, including unit dose laundry detergent; the impact of foreign exchange and commodity price fluctuations; the Company’s investments in joint ventures; the impact of acquisitions and divestitures; capital expenditures; pension settlement charges; the Company’s share repurchase programs and the Company’s effective tax rate. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that could cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; delays or other problems in manufacturing or distribution; adverse developments affecting the financial condition of major customers and suppliers; competition, including The Procter & Gamble Company’s participation in the value laundry detergent category and Henkel AG & Co. KGaA's ("Henkel") entry into the U.S. premium laundry detergent category; Henkel’s acquisition of The Sun Products Co., Inc.; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; the Company’s ability to maintain product quality and characteristics at a level acceptable to our customers and consumers; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; implications of the United Kingdom’s withdrawal from the European Union; issues relating to the Company’s information technology and controls; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U. S. federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the Commission.

Risk factors

As filed, 252 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2017-01-01 to 2017-03-31$477.9mus-gaap:CostOfGoodsSold
Gross profit3 months2017-01-01 to 2017-03-31$399.3mus-gaap:GrossProfit
Research and development3 months2017-01-01 to 2017-03-31$14.1mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2017-01-01 to 2017-03-31$112.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-01-01 to 2017-03-31$196.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-01-01 to 2017-03-31$8.2mus-gaap:InterestExpense
Income tax3 months2017-01-01 to 2017-03-31$58.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-01-01 to 2017-03-31$131.5mus-gaap:ProfitLoss
Diluted EPS3 months2017-01-01 to 2017-03-31$0.51us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-01-01 to 2017-03-31$0.52us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2017-01-01 to 2017-03-31259,700,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2017-01-01 to 2017-03-31$131.5mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure3 months2017-01-01 to 2017-03-31$2.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2017-01-01 to 2017-03-31$48.4mus-gaap:PaymentsOfDividends
Share repurchases3 months2017-01-01 to 2017-03-31$157.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-03-31$139.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-03-31$754.5mus-gaap:AssetsCurrent
Total assetsAt period end2017-03-31$4.49bnus-gaap:Assets
Current liabilitiesAt period end2017-03-31$1.17bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-03-31$2.55bnus-gaap:Liabilities
Long-term debtAt period end2017-03-31$692.9mus-gaap:LongTermDebtNoncurrent
Short-term borrowingsAt period end2017-03-31$585.7mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2017-03-31$1.94bnus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001564590-17-008613. Last ingested by Listed: Nov 14, 2026, 21:34 ET. Listed shows no prices and gives no investment advice.